NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002152

Registered date:01/07/2009

A phase 1 study of combination therapy with gemcitabine and candesartan in patients with pancreatic cancer

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedPancreatic cancer
Date of first enrollment2009/07/01
Target sample size24
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Combination therapy with gemcitabine and candesartan

Outcome(s)

Primary OutcomeDose limiting toxicity, maximum tolerated dose, recommended dose
Secondary OutcomeAdverse effects, response rate, disease control rate, progression free survival, overall survival

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1) Patients with systolic blood pressure < 100mmHg 2) Patients with an active concomitant infection 3) Patients with digestive ulcer or gastrointestinal bleeding 4) Patients with severe heart or renal disease 5) Patients with an active pulmonary fibrosis or interstitial pneumonia 6) Patients with a previous history of a severe drug hypersensitivity 7) Patients with an active concomitant malignancy 8) Pregnant, lactating female and patients of reproductive potential who did not use effective contraception 9) Patients with hypertension 10) Patients who received ACE or ARB 11) Patients with uncontrollable massive pleural effusion or massive ascites 12) Inappropriate patients for entry on this study in the judgement of the investigator

Related Information

Contact

public contact
Name Yousuke Nakai
Address Japan
Telephone
E-mail ynakai-tky@umin.ac.jp
Affiliation University of Tokyo Department of Gastroenterology
scientific contact
Name Hiroyuki Isayama
Address 7-3-1 Hongo, Bunkyo-ku, Tokyo Japan
Telephone
E-mail
Affiliation University of Tokyo Department of Gastroenterology